SCHEMBL21946319

SCHEMBL21946319

NC(=O)c1ncc(N2CCCCCCCC2)nc1Nc1ccc(N2CCNCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 10/20 0.59
▸ LCK P06239 9/20 0.59
▸ JAK3 P52333 14/20 0.57
▸ EGFR P00533 2/20 0.53
▸ SYK P43405 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21855202 1.00 BTK (0.59) BTKLCKJAK3EGFRSYK
SCHEMBL18884637 0.94 BTK (0.64) BTKLCKJAK3EGFRSYK
SCHEMBL18884550 0.88 JAK3 (0.62) BTKLCKJAK3SYK
SCHEMBL21947866 0.88 BTK (0.55) BTKLCKJAK3EGFR
SCHEMBL21946745 0.88 CDK4 (0.49) BTKLCKJAK3EGFRSYK
SCHEMBL25605387 0.88 BTK (0.59) BTKLCKJAK3EGFR
SCHEMBL18296155 0.88 LCK (0.73) BTKLCKJAK3EGFRSYK
SCHEMBL18884392 0.87 JAK3 (0.69) BTKLCKJAK3EGFRSYK
SCHEMBL25605382 0.87 BTK (0.62) BTKLCKJAK3EGFRSYK
SCHEMBL21947880 0.86 BTK (0.57) BTKLCKJAK3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081450-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2020-04-23 — — WO disclosed
Send feedback